Nestlé Health Science announced that it will make an equity investment of $145m in US-based Aimmune Therapeutics, which corresponds to a 15% stake after completion of the transaction. The parties also entered into a strategic ...
Tags: Food Allergies, Nestle
Following greatly increased use in the optical communications industry over the past 15 years, the global market for vertical-cavity surface-emitting lasers (VCSELs) will grow at a five-year compound annual growth rate (CAGR) of 21.9% from ...
Tags: VCSELs, VCSEL Market, CAGR
Scientists are currently in the process of developing pills which mimic the effects of exercise. A review published in the October 2015 edition of Trends in Pharmacological Sciences, (Vol. 36) examines the work of several laboratories ...
UVLrx Therapeutics announces that it has received CE marking to commercially sell its UVLrx 1500 multi-wavelength, intravenous light therapy system in the European Union. The UVLrx 1500 System offers the first intravenous, concurrent ...
Tags: UVLrx, UV LED Therapy Device, EU Consumers
The FDA won’t let 23andMe sell its Personal Genomic Service tests to consumers in the United States, but that hasn’t stopped the company from selling its customers’ anonymous information to other companies for research. ...
Perkasie, PA – Secant Medical will present at Rice University’s Advances in Tissue Engineering 2014 22nd Annual Short Course in Houston, August 13-16. Jeremy Harris, Ph.D., Technical Director at Secant Medical, will discuss how ...
Tags: Secant Medical, Tissue Engineering, Medicine
Limiting saturated fat intake could help those with a genetic predisposition to obesity Limiting saturated fat could help people whose genetic make-up increases their likelihood of being obese, according to a new study from the Jean Mayer ...
Tags: Agriculture, Food
It seems that a fight is looming over a seat on Echo Therapeutics Inc.'s board of directors. The company's largest shareholder, an investor group led by Platinum Management (NY), LLC, which owns approximately 19.9% of Echo's common ...
Anika Therapeutics (ANIK) has received marketing approval for MONOVISC from the US Food and Drug Administration (FDA) for the treatment of patients suffering from osteoarthritis (OA) of the knee. MONOVISC is a single injection supplement ...
Tags: FDA Approval, Anika
Work uncovers secret of how genome-editing tool works as a 'guided missile' to correct errors in the genetic code Researchers from the Broad Institute and MIT have teamed up with colleagues from the University of Tokyo to form the first ...
In research that could ultimately lead to many new medicines, scientists from the Florida campus of The Scripps Research Institute (TSRI) have developed a potentially general approach to design drugs from genome sequence. As a proof of ...
Tags: Identify New Drug Candidates, unparalleled selectivity, cell permeable
Scientists at the University of Kansas Medical Center have determined that high doses of vitamin C, administered intravenously with traditional chemotherapy, helped kill cancer cells while reducing the toxic effects of chemotherapy for some ...
Pluristem Therapeutics, a developer of placenta-based cell therapies, has been granted a new patent by the Australian Patent Office. Patent #2007228341 covers the method and composition of matter for three-dimensional (3D) expansion of ...
Tags: 3D Cell Expansion, Pluristem
DTect-All(TM) platform will be used to screen for GPCR-directed allosteric modulator antibodies Domain Therapeutics, a biopharmaceutical company specializing in the research and development of new drug candidates targeting G ...
Tags: DTect-All(TM)
TUESDAY Feb. 4, 2014, 2014 -- In a first-of-its-kind initiative, the U.S. National Institutes of Health has partnered with 10 drug companies and several nonprofit groups to speed development of biological ways of diagnosing and treating ...